The Effect of Nursing Follow-Up by Phone on The Self-Efficacy,Pain,Disease Activity in Rheumatoid Arthritis Patients
Tele-nursing
About this trial
This is an interventional supportive care trial for Tele-nursing focused on measuring Rheumatoid Arthritis, Biological Agent, Telephone Monitoring, Nursing Practices
Eligibility Criteria
Inclusion Criteria: Having been diagnosed with rheumatoid arthritis for at least 1 year, To have received at least 3 doses of biologic agent subcutaneously within the DMARD combination treatment option, Not having problems in communicating, Having no mental problems, hearing and vision problems, Being 18 years or older, Being conscious, Being able to communicate by phone, Applying to Sivas Numune Hospital Rheumatology Polyclinic, No planned training by health professionals on RA and biological agent therapy before, Agree to participate in the study. Exclusion Criteria: Losing one's life during the research period, Termination of biological agent treatment for any reason, Leaving the research voluntarily.
Sites / Locations
- Döne Günay
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention Group
Control Group
Data collection tools were applied face to face. Patient education was carried out in the polyclinic. A training booklet was given at the end of the training. Afterwards, patients were called once a week by telephone for 12 weeks. The patients were followed up by the nurse over the phone and counseling was provided to the patients. Patients were able to call the research nurse when needed. Interim evaluation was made at the 12th week. Data collection tools were applied face-to-face in the outpatient clinic. Patients 13-24. Between weeks, 12 more phone calls were made, once a week. The patients were followed up by the nurse by telephone, and the patients continued to receive counseling services. Patients were able to call the research nurse when needed. At the end of the 24th week, the research forms were applied face to face in the outpatient clinic. The research has finished.
Individuals meeting the sample specifications were included in the control group in accordance with the order of numbers in the lists created by randomly assigning numbers. Data collection tools were applied face to face. Routine outpatient follow-ups continued. Interim evaluation was made at the 12th week. In the interim evaluation, data collection tools were applied face to face. Then, routine outpatient follow-up between 13 and 24 weeks continued. At the end of the 24th week, data collection tools were applied face to face. The patients were educated in the outpatient clinic. A training booklet was given at the end of the training. The research has been terminated.